Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director
Quarterly results
Acq. announced

ANI PHARMACEUTICALS INC (ANIP) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/16/2019 GN Investor Expectations to Drive Momentum within uniQure N.V., Aflac, ANI Pharmaceuticals, MaxLinear, ZAGG, and Aqua America — Discovering Underlying Factors of Influence
02/13/2019 GN Factors of Influence in 2019, Key Indicators and Opportunity within Amkor Technology, U.S. Silica, Steven Madden, Rowan Companies, SunOpta, and ANI Pharmaceuticals — New Research Emphasizes Economic Growth
08/27/2018 GN Recent Analysis Shows KalVista Pharmaceuticals, IZEA, Sonic Automotive, Catabasis Pharmaceuticals, ANI Pharmaceuticals, and Clovis Oncology Market Influences — Renewed Outlook, Key Drivers of Growth
06/25/2018 GN Market Trends Toward New Normal in EnviroStar, Rowan Companies, Del Taco Restaurants, ANI Pharmaceuticals, Infinity Property and Casualty, and Viacom — Emerging Consolidated Expectations, Analyst Ratings
05/07/2018 GN Market Trends Toward New Normal in Viacom, Nutanix, ANI Pharmaceuticals, PACCAR, Cabot Oil & Gas, and Box — Emerging Consolidated Expectations, Analyst Ratings
03/05/2018 GN Detailed Research: Economic Perspectives on Lear, MYOS RENS Technology, Dollar Tree, Halliburton, Waters, and ANI Pharmaceuticals — What Drives Growth in Today's Competitive Landscape
11/02/2017 GN Report: Developing Opportunities within Echelon, NII Holdings, ANI Pharmaceuticals, Zion Oil & Gas, vTv Therapeutics, and Sears Holdings – Future Expectations, Projections Moving into 2018
04/04/2012 PRN Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position
07/21/2011 BW BioSante Pharmaceuticals Signs Melanoma Vaccine License
06/07/2011 BW BioSante Pharmaceuticals, Inc. To Present at Jefferies Global Healthcare Conference
05/18/2011 BW BioSante Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences
05/10/2011 BW BioSante Pharmaceuticals Reports First Quarter Financial Results and Recent Developments
04/27/2011 BW BioSante Pharmaceuticals, Inc. To Present at the Deutsche Bank Annual Health Care Conference
04/18/2011 BW BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License
04/13/2011 BW BioSante Pharmaceuticals Announces Teva New Drug Application for Bio-T-Gel™
04/11/2011 BW BioSante Pharmaceuticals, Inc. To Present at Future Leaders in the Biotech Industry Conference
03/30/2011 BW BioSante Pharmaceuticals Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials
03/17/2011 MW Speculative Biotech Firms Remain Popular Takeover Targets
03/16/2011 BW BioSante Pharmaceuticals Reports Financial Results for 2010 and Clinical Development and Business Highlights
03/09/2011 BW BioSante Pharmaceuticals Closes $25.1 Million Registered Direct Offering
03/04/2011 BW BioSante Pharmaceuticals to Raise $25.1 Million in Registered Direct Offering
03/03/2011 BW BioSante's Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study
02/24/2011 BW BioSante Pharmaceuticals Completes Enrollment in LibiGel® Phase III Efficacy Trial
02/22/2011 BW BioSante Pharmaceuticals, Inc. to Present at Citi Global Health Care Conference
02/15/2011 BW BioSante Presents Data Showing Female Sexual Dysfunction is a Significant Unmet Medical Need
02/14/2011 BW BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data in Phase III Program
02/14/2011 BW BioSante Pharmaceuticals, Inc. To Present LibiGel® Safety Study Update at BIO CEO & Investor Conference
02/12/2011 BW BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data in Phase III Program
01/10/2011 MW Exciting Opportunities Emerge in Biotech Sector
11/17/2010 BW BioSante Pharmaceuticals Sells Oncolytic Virus Technology to Cold Genesys, Inc.
11/12/2010 BW BioSante Pharmaceuticals Reports Third Quarter 2010 Financial Results
10/26/2010 BW BioSante Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences
10/25/2010 BW BioSante Pharmaceuticals Reports Positive LibiGel® Data Monitoring Committee Recommendation
10/18/2010 BW BioSante Pharmaceuticals Reaches Key LibiGel® Safety Study Enrollment Target
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy